We’re delighted to be featured by Technology Networks in this interview with our co-founders, Dr Lara Zibners and Thang Vo-Ta, about our Callavid® intravaginal drug delivery platform.

Our first focus is progesterone delivery for threatened miscarriage and IVF– areas where the clinical need is significant, but where the patient experience has too often been overlooked.

Callavid is designed to fit a woman’s physiology, anatomy and lifestyle. Our NIHR funded FREEDOM trial at University Hospitals Coventry and Warwickshire (UHCW) NHS Trust is an important step in evaluating the safety of progesterone delivery using our platform.

The article also explores the broader opportunity: how drug-device combination products could help create more precise, more comfortable and more patient-centred solutions across women’s health.

Thank you to Izzy Hirst and Technology Networks for shining a light on our work.

full article here: https://www.technologynetworks.com/tn/blog/a-first-in-woman-study-tampon-based-drug-delivery-device-enters-clinical-trials-413737